| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $65.0M | -23.9% |
| Cost of Revenue | $51.7M | -4.0% |
| R&D Expense | $64.9M | +31.6% |
| SG&A Expense | $64.0M | +34.1% |
| Operating Income | -$115.5M | -76.8% |
| Interest Expense | $201K | +9.2% |
| Pre-tax Income | -$113.3M | -73.7% |
| Income Tax | $40K | +185.7% |
| Net Income | -$113.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $89.1M | -15.6% |
| Short-term Investments | $78.5M | -56.7% |
| Accounts Receivable | $16.6M | -9.9% |
| Current Assets | $199.7M | -37.2% |
| Total Assets | $292.7M | -26.2% |
| Current Liabilities | $33.1M | +5.8% |
| Total Liabilities | $74.6M | -13.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.2M | +0.8% |
| Capital Expenditures | $49.9M | +350.2% |
| Investing Cash Flow | $52.5M | +187.5% |
| Financing Cash Flow | $1.4M | -99.2% |
| Free Cash Flow | -$120.1M | -46.7% |
| -73.7% |
| EPS (Basic) | -$2.48 | -66.4% |
| EPS (Diluted) | -$2.48 | -66.4% |
| Stockholders' Equity |
| $218.1M |
| -29.7% |